title: Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.
abstract: Permanent disability of patients suffering from central nervous system (CNS) inflammation such as multiple sclerosis, the most common chronic inflammatory disorder of the CNS, originates mainly from demyelination and axonal damage. Although many studies in the past focused on the role of CD4(+) T cells, several recent findings postulate the relevance of autoaggressive, cytotoxic CD8(+) T cells in the effector phase of multiple sclerosis. Yet, it remains unresolved whether axonal injury is the result of a CD8(+) T cell-targeted hit against the axon itself or the consequence of an attack against the myelin structure. To address this issue of CD8-mediated tissue damage in CNS inflammation, we performed continuous confocal imaging of autoaggressive, cytotoxic CD8(+) T cells in living organotypic cerebellar brain slices. We observed that loading brain slices with the cognate peptide antigen caused CD8-mediated damage of myelinated axons. To exclude the possibility that the cognate peptide loaded onto the brain slices was presented by axons directly, we restricted the cognate antigen expression exclusively to the cytosol of oligodendrocytes. Aside from vast myelin damage, extensive axonal bystander injury occurred. Using this model system of inflammatory CNS injury, we visualize that axonal loss can be the consequence from "collateral bystander damage" by autoaggressive, cytotoxic CD8(+) T cells, targeting their cognate antigen processed and presented by oligodendrocytes.
authors.affiliation: Department of Neurology, Heinrich-Heine-University, Moorenstrasse 5, Duesseldorf, Germany.
authors.forename: Bettina
authors.initials: B
authors.lastname: Sobottka
authors.forename: Melanie Denise
authors.initials: MD
authors.lastname: Harrer
authors.forename: Urs
authors.initials: U
authors.lastname: Ziegler
authors.forename: Katja
authors.initials: K
authors.lastname: Fischer
authors.forename: Heinz
authors.initials: H
authors.lastname: Wiendl
authors.forename: Thomas
authors.initials: T
authors.lastname: Hünig
authors.forename: Burkhard
authors.initials: B
authors.lastname: Becher
authors.forename: Norbert
authors.initials: N
authors.lastname: Goebels
mesh_terms: D000818:Animals; D001324:Autoantigens / Q000276:immunology; D015551:Autoimmunity; D001369:Axons / Q000276:immunology / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002490:Central Nervous System / Q000276:immunology* / Q000473:pathology*; D003602:Cytotoxicity, Immunologic; D051379:Mice; D008822:Mice, Transgenic; D009103:Multiple Sclerosis / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D009186:Myelin Sheath / Q000276:immunology* / Q000473:pathology*; D009836:Oligodendroglia / Q000276:immunology / Q000473:pathology / Q000648:ultrastructure; D009924:Organ Culture Techniques
chemical_list: D001324:Autoantigens
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2428-33
references.pmid: 14983026
references.citation: Nat Immunol. 2006 Sep;7(9):946-53
references.pmid: 16906165
references.citation: J Immunol. 2001 Jun 15;166(12):7579-87
references.pmid: 11390514
references.citation: Am J Pathol. 2001 Sep;159(3):809-15
references.pmid: 11549572
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14145-50
references.pmid: 14610278
references.citation: J Mol Med (Berl). 2006 Jul;84(7):532-43
references.pmid: 16773356
references.citation: J Neurosci. 1998 Oct 15;18(20):8331-43
references.pmid: 9763477
references.citation: Blood. 2004 Jun 1;103(11):4222-31
references.pmid: 14976054
references.citation: J Immunol. 1996 Jul 15;157(2):679-88
references.pmid: 8752917
references.citation: J Immunol. 1998 Mar 15;160(6):3056-9
references.pmid: 9510211
references.citation: J Neurosci. 2007 Feb 21;27(8):2013-24
references.pmid: 17314297
references.citation: Annu Rev Immunol. 1999;17:369-97
references.pmid: 10358763
references.citation: J Immunol. 2008 Aug 1;181(3):1617-21
references.pmid: 18641296
references.citation: Mol Cell Neurosci. 1998 Dec;12(6):376-89
references.pmid: 9888990
references.citation: Brain. 2005 Aug;128(Pt 8):1747-63
references.pmid: 15975943
references.citation: J Exp Med. 2005 Jun 6;201(11):1805-14
references.pmid: 15939794
references.citation: J Exp Med. 2000 Aug 7;192(3):393-404
references.pmid: 10934227
references.citation: J Exp Med. 2001 Sep 3;194(5):669-76
references.pmid: 11535634
references.citation: J Neurosci. 2004 Mar 10;24(10):2458-64
references.pmid: 15014121
references.citation: N Engl J Med. 2006 Mar 2;354(9):942-55
references.pmid: 16510748
references.citation: Trends Neurosci. 2002 Jun;25(6):313-9
references.pmid: 12086750
references.citation: Eur J Immunol. 2006 Jan;36(1):207-15
references.pmid: 16342234
references.citation: J Neurosci Methods. 1991 Apr;37(2):173-82
references.pmid: 1715499
references.citation: Exp Neurol. 2009 Apr;216(2):431-8
references.pmid: 19320002
references.citation: J Exp Med. 1982 Jun 1;155(6):1823-41
references.pmid: 6176669
references.citation: Nat Immunol. 2001 Sep;2(9):762-4
references.pmid: 11526378
references.citation: Brain. 2008 Sep;131(Pt 9):2353-65
references.pmid: 18669487
references.citation: Trends Neurosci. 1997 Oct;20(10):471-7
references.pmid: 9347615